浙商中拓(000906.SZ):前三季度淨利潤預增50.08%
格隆匯10月14日丨浙商中拓(000906.SZ)公佈了前三季度業績預吿,公司預計2021年前三季度實現歸屬於上市公司股東的淨利潤為6.1億元,同比增長50.08%。
業績變動主要原因為:
報吿期內,公司聚焦生產性服務業,圍繞打造“成為世界一流的產業鏈組織者和供應鏈管理者”的願景目標和“十四五”戰略規劃,加速京津冀、長三角、珠三角等重點經濟區域佈局,深入推進組織機構改革,持續引進優秀團隊,夯實數字天網、物流地網等基礎配套設施,不斷提升供應鏈集成服務能力,創新產業鏈商業模式,完善風險管控體系,強化訂單管理、庫存管理和價格管理,加速資產週轉,經營質量和經營效益持續提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.